<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08809369094093</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:56.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809369094086</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:55.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809369093355</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:28.037Z</lastUpdated>
  </row>
</eudamedExport>